Amphastar Pharmaceuticals, Inc. (AMPH) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 6 Buy, 6 Hold.
The consensus price target is $30.00, representing an upside of 40.3% from the current price $21.38.
Analysts estimate Earnings Per Share (EPS) of $3.87 and revenue of $0.73B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $3.29 vs est $3.87 (missed -15%). 2025: actual $2.10 vs est $3.44 (missed -38.9%). Analyst accuracy: 59%.
AMPH Stock — 12-Month Price Forecast
$30.00
▲ +40.32% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for Amphastar Pharmaceuticals, Inc., the price target is $30.00.
The average price target represents a +40.32% change from the last price of $21.38.
AMPH Analyst Ratings
Buy
Based on 12 analysts giving stock ratings to Amphastar Pharmaceuticals, Inc. in the past 3 months
EPS Estimates — AMPH
59%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $3.29
vs Est $3.87
▼ 17.7% off
2025
Actual $2.10
vs Est $3.44
▼ 63.7% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — AMPH
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.713B
vs Est $0.734B
▼ 3.0% off
2025
Actual $0.720B
vs Est $0.726B
▼ 0.8% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
